Asthma medication use among adults with current asthma by work-related asthma status, Asthma Call-back Survey, 29 states, 2012–2013

References

• Moorman JE, Akinbami LJ, Bailey CM, Zahran HS, King ME, Johnson CA, et al. National surveillance of asthma: United States, 2001–2010. Vital Health Stat 2012;3(35):1–67.
   Google Scholar
• Expert Panel Report 3 (EPR-3). Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol 2007;120(5 Suppl):S94–138.
   PubMedGoogle Scholar
• Knoeller GE, Mazurek JM, Moorman JE. Characteristics associated with health care professional diagnosis of work-related asthma among individuals who describe their asthma as being caused or made worse by workplace exposures. J Occup Environ Med 2012;54(4):485–490.
   PubMed Web of Science ®Google Scholar
• Tarlo SM, Balmes J, Balkissoon R, Beach J, Beckett W, Bernstein D, et al. Diagnosis and management of work-related asthma: American College of Chest Physicians Consensus Statement. Chest 2008;134(3 Suppl):1S–41S.
   PubMed Web of Science ®Google Scholar
• Galanter J, Boushey H. Chapter 20: Drugs Used in Asthma. In: Katzung B, Trevor A, editors. Basic & clinical pharmacology. 13th ed. New York, NY: McGraw-Hill; 2015:339–357.
   Google Scholar
• Vandenplas O, Dressel H, Nowak D, Jamart J. What is the optimal management option for occupational asthma? Eur Respir Rev 2012;21(124):97–104.
   PubMedGoogle Scholar
• Tarlo S. Clinical aspects of work-related asthma: past achievements, persistent challenges, and emerging triggers. J Occup Environ Med 2014;56 Suppl 10:S40–44.
   PubMed Web of Science ®Google Scholar
• Baur X, Sigsgaard T, Aasen TB, Burge PS, Heederik D, Henneberger P, et al. Guidelines for the management of work-related asthma. Eur Respir J 2012;39(3):529–545.
   PubMed Web of Science ®Google Scholar
• Knoeller GE, Mazurek JM, Moorman JE. Work-related asthma, financial barriers to asthma care, and adverse asthma outcomes: Asthma Call-Back survey, 37 states and District of Columbia, 2006 to 2008. Med Care 2011;49(12):1097–1104.
   PubMed Web of Science ®Google Scholar
• Zahran HS, Bailey CM, Qin X, Moorman JE. Assessing asthma control and associated risk factors among persons with current asthma - findings from the child and adult Asthma Call-back Survey. J Asthma 2015;52(3):318–326.
   PubMed Web of Science ®Google Scholar
• Zahran HS, Bailey CM, Qin X, Johnson C. Long-term control medication use and asthma control status among children and adults with asthma. J Asthma 2017. Epub.
   Web of Science ®Google Scholar
• Knoeller GE, Mazurek JM, Moorman JE. Asthma symptoms among adults with work-related asthma. J Asthma 2013;50(2):166–173.
   PubMed Web of Science ®Google Scholar
• Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009;180(1):59–99.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System. Updated March 19; Accessed April 27, 2015. Available from: http://www.cdc.gov/brfss/about/index.htm.
   Google Scholar
• Centers for Disease Control and Prevetion (CDC). BRFSS Asthma Call-back Survey. Updated June 9; Accessed April 27, 2015. Available from: http://www.cdc.gov/brfss/acbs/index.htm.
   Google Scholar
• Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 2014;43(2):343–373.
   Google Scholar
• Knoeller GE, Mazurek JM, Moorman JE. Work-related asthma among adults with current asthma in 33 states and DC: evidence from the Asthma Call-back Survey, 2006–2007. Public Health Rep 2011;126(4):603–611.
   Google Scholar
• Deshpande M, Chewning B, Mott D, Thorpe JM, Young HN. Asthma medication use among late midlife US Adults. J Asthma 2016;53(3):261–268.
   Google Scholar
• Henneberger PK, Redlich CA, Callahan DB, Harber P, Lemiere C, Martin J, et al. An official American Thoracic Society statement: work-exacerbated asthma. Am J Respir Crit Care Med 2011;184(3):368–378.
   Google Scholar
• Legiest B, Nemery B. Management of work-related asthma: guidelines and challenges. Eur Respir Rev 2012;21(124):79–81.
   Google Scholar
• Mazurek JM, Storey E. Physician-patient communication regarding asthma and work. Am J Prev Med 2012;43(1):72–75.
   Google Scholar
• Vandenplas O, Toren K, Blanc PD. Health and socioeconomic impact of work-related asthma. Eur Respir J 2003;22(4):689–697.
   Google Scholar
• Alvarado-Gonzalez A, Arce I. Tiotropium Bromide in chronic obstructive pulmonary disease and bronchial asthma. J Clin Med Res 2015;7(11):831–839.
   Google Scholar
• Global Initiative for Asthma GIfCOLD. Diagnosis of Diseases of Chronic Airflow Limitation: Asthma COPD and Asthma-COPD Overlap Syndrome (ACOS). 2015.
   Google Scholar
• van den Berge M, Aalbers R. The asthma-COPD overlap syndrome: how is it defined and what are its clinical implications? J Asthma Allergy 2016;9:27–35.
   Google Scholar
• Nielsen M, Barnes CB, Ulrik CS. Clinical characteristics of the asthma-COPD overlap syndrome–a systematic review. Int J Chron Obstruct Pulmon Dis 2015;10:1443–1454.
   Google Scholar
• Alshabanat A, Zafari Z, Albanyan O, Dairi M, FitzGerald JM. Asthma and COPD overlap syndrome (ACOS): A systematic review and meta analysis. PLoS One 2015;10(9):e0136065.
   Google Scholar
• Malo JL, Tarlo SM, Sastre J, Martin J, Jeebhay MF, Le Moual N, et al. An official American Thoracic Society Workshop Report: presentations and discussion of the fifth Jack Pepys Workshop on Asthma in the Workplace. Comparisons between asthma in the workplace and non-work-related asthma. Ann Am Thoracic Soc 2015;12(7):S99–s110.
   Google Scholar
• Scichilone N. Asthma control: the right inhaler for the right patient. Adv Ther 2015;32(4):285–292.
   Google Scholar
• Price D, Harrow B, Small M, Pike J, Higgins V. Establishing the relationship of inhaler satisfaction, treatment adherence, and patient outcomes: a prospective, real-world, cross-sectional survey of US adult asthma patients and physicians. World Allergy Org J 2015;8(1):26.
   Google Scholar
• Zahran HS, Person CJ, Bailey C, Moorman JE. Predictors of asthma self-management education among children and adults–2006–2007 Behavioral Risk Factor Surveillance System Asthma Call-back Survey. J Asthma 2012;49(1):98–106.
   Google Scholar
• Federman AD, Wolf M, Sofianou A, Wilson EA, Martynenko M, Halm EA, Leventhal H, et al. The association of health literacy with illness and medication beliefs among older adults with asthma. Patient Educ Couns 2013;92(2):273–278.
   Google Scholar
• Ponieman D, Wisnivesky JP, Leventhal H, Musumeci-Szabo TJ, Halm EA. Impact of positive and negative beliefs about inhaled corticosteroids on adherence in inner-city asthmatic patients. Ann Allergy Asthma Immunol 2009;103(1):38–42.
   Google Scholar
• Barnes PJ. Achieving asthma control. Curr Med Res Opin 2005;21(Suppl 4):S5–9.
   Google Scholar
• Moore WC, Hastie AT, Li X, Li H, Busse WW, Jarjour NN, Wenzel SE, et al. Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis. J Allergy Clin Immunol 2014;133(6):1557–1563.
   Google Scholar
• de Nijs SB, Venekamp LN, Bel EH. Adult-onset asthma: is it really different? Eur Respir Rev 2013;22(127):44–52.
   Google Scholar
• U.S. Food and Drug Administration. Omalizumab Product Approval Information - Licensing Action. Updated May 6, 2016; Accessed August 1, 2016. Available from: http://www.fda.gov/drugs/developmentapprovalprocess/howdrugsaredevelopedandapproved/approvalapplications/therapeuticbiologicapplications/ucm093373.htm.
   Google Scholar
• Omalizumab [package insert]. Genentech, Inc., South San Francisco, CA. Accessed August 1, 2016. Available from: http://www.fda.gov/downloads/drugs/developmentapprovalprocess/howdrugsaredevelopedandapproved/approvalapplications/therapeuticbiologicapplications/ucm113454.pdf.
   Google Scholar
• U.S. Food and Drug Administration. Cinqair (reslizumab). Updated 5 May 2016. Available from: http://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/761033Orig1s000TOC.cfm [last accessed 22 August 016].
   Google Scholar
• U.S. Food and Drug Administration. Nucala (mepolizumab) Lyophilized Powder for Subcutaneous Injection. Updated 11 December 2015. Available from: http://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/125526Orig1s000TOC.cfm [last accessed 22 August 2016].
   Google Scholar
• Heederik D, Henneberger PK, Redlich CA. Primary prevention: exposure reduction, skin exposure and respiratory protection. Eur Respir Rev 2012;21(124):112–124.
   Google Scholar